Active Ingredient: ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Proprietary Name: CABTREO
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 0.15%;3.1%;1.2%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216632
Product Number: 001
Approval Date: Oct 20, 2023
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
